ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Management Survey Finds Problems At ACS, Advises Change

July 3, 1992

Also NCI prostate SPOREs plan biospecimen bank.

December 10, 2004

The Administration: Gore Marks 2nd Year of Tumor Gene Index, Honors Armstrong, Cancer Survivors

September 3, 1999

Rauscher Decision Put Off To July 1: Administration Backs Pay Raise Bill

June 25, 1976

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

More Changes In Carcinogenesis Program At NCI: Gori, Workshops Out, Branch Chiefs Running It

November 18, 1977